(Q41277166)

English

Association between nucleos(t)ide analog and tumor recurrence in hepatitis B virus-related hepatocellular carcinoma after radiofrequency ablation

scientific article published on October 2015

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

29 September 2017

Association between nucleos(t)ide analog and tumor recurrence in hepatitis B virus-related hepatocellular carcinoma after radiofrequency ablation (English)

1 reference

Europe PubMed Central

PubMed publication ID

29 September 2017

Hepatitis B virus

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Teng-Yu Lee

1

1 reference

Europe PubMed Central

PubMed publication ID

29 September 2017

Jaw-Town Lin

2

1 reference

Europe PubMed Central

PubMed publication ID

29 September 2017

Yi-Siou Zeng

3

1 reference

Europe PubMed Central

PubMed publication ID

29 September 2017

Yi-Ju Chen

4

1 reference

Europe PubMed Central

PubMed publication ID

29 September 2017

Ming-Shiang Wu

5

1 reference

Europe PubMed Central

PubMed publication ID

29 September 2017

Chun-Ying Wu

6

1 reference

Europe PubMed Central

PubMed publication ID

29 September 2017

language of work or name

0 references

publication date

1 October 2015

1 reference

Europe PubMed Central

PubMed publication ID

29 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

29 September 2017

63

1 reference

Europe PubMed Central

PubMed publication ID

29 September 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

29 September 2017

1517-1527

1 reference

Europe PubMed Central

PubMed publication ID

29 September 2017

Global cancer statistics

1 reference

https://api.crossref.org/works/10.1002%2FHEP.28266

21 January 2018

Epidemiology of hepatocellular carcinoma: consider the population

1 reference

https://api.crossref.org/works/10.1002%2FHEP.28266

21 January 2018

Evaluation of abdominal ultrasonography mass screening for hepatocellular carcinoma in Taiwan

1 reference

https://api.crossref.org/works/10.1002%2FHEP.28266

21 January 2018

Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.28266

21 January 2018

Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation

1 reference

https://api.crossref.org/works/10.1002%2FHEP.28266

21 January 2018

Treatment of intermediate-stage hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FHEP.28266

21 January 2018

A randomized controlled trial of radiofrequency ablation and surgical resection in the treatment of small hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.28266

21 January 2018

A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FHEP.28266

21 January 2018

EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FHEP.28266

21 January 2018

Management of hepatocellular carcinoma: An update

1 reference

https://api.crossref.org/works/10.1002%2FHEP.28266

21 January 2018

Efficacy and long-term outcomes of radiofrequency ablation in the elderly with hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FHEP.28266

21 January 2018

Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level

1 reference

https://api.crossref.org/works/10.1002%2FHEP.28266

21 January 2018

Hepatitis C virus seromarkers and subsequent risk of hepatocellular carcinoma: long-term predictors from a community-based cohort study

1 reference

https://api.crossref.org/works/10.1002%2FHEP.28266

21 January 2018

Lamivudine for patients with chronic hepatitis B and advanced liver disease

1 reference

https://api.crossref.org/works/10.1002%2FHEP.28266

21 January 2018

Meta-analysis: Treatment of hepatitis B infection reduces risk of hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.28266

21 January 2018

Systematic review: outcome of compensated cirrhosis due to chronic hepatitis C infection.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.28266

21 January 2018

Association of nucleos(t)ide analogue therapy with reduced risk of hepatocellular carcinoma in patients with chronic hepatitis B: a nationwide cohort study

1 reference

https://api.crossref.org/works/10.1002%2FHEP.28266

21 January 2018

Radiofrequency ablation for hepatocellular carcinoma: 10-year outcome and prognostic factors.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.28266

21 January 2018

Comparison of resection and ablation for hepatocellular carcinoma: a cohort study based on a Japanese nationwide survey

1 reference

https://api.crossref.org/works/10.1002%2FHEP.28266

21 January 2018

Persistent hepatitis B viral replication affects recurrence of hepatocellular carcinoma after curative resection.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.28266

21 January 2018

Low hepatitis C viral load predicts better long-term outcomes in patients undergoing resection of hepatocellular carcinoma irrespective of serologic eradication of hepatitis C virus

1 reference

https://api.crossref.org/works/10.1002%2FHEP.28266

21 January 2018

Association between nucleoside analogues and risk of hepatitis B virus–related hepatocellular carcinoma recurrence following liver resection

1 reference

https://api.crossref.org/works/10.1002%2FHEP.28266

21 January 2018

Impact of antiviral therapy on the survival of patients after major hepatectomy for hepatitis B virus-related hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FHEP.28266

21 January 2018

Adjuvant interferon therapy after curative therapy for hepatocellular carcinoma (HCC): a meta-regression approach

1 reference

https://api.crossref.org/works/10.1002%2FHEP.28266

21 January 2018

Postoperative peg-interferon plus ribavirin is associated with reduced recurrence of hepatitis C virus-related hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FHEP.28266

21 January 2018

Effective reduction of gastric cancer risk with regular use of nonsteroidal anti-inflammatory drugs in Helicobacter pylori-infected patients

1 reference

https://api.crossref.org/works/10.1002%2FHEP.28266

21 January 2018

Early Helicobacter pylori eradication decreases risk of gastric cancer in patients with peptic ulcer disease

1 reference

https://api.crossref.org/works/10.1002%2FHEP.28266

21 January 2018

Metformin decreases hepatocellular carcinoma risk in a dose-dependent manner: population-based and in vitro studies

1 reference

https://api.crossref.org/works/10.1002%2FHEP.28266

21 January 2018

A tool to predict risk for gastric cancer in patients with peptic ulcer disease on the basis of a nationwide cohort

1 reference

https://api.crossref.org/works/10.1002%2FHEP.28266

21 January 2018

Radiofrequency ablation for hepatocellular carcinoma: use of low vs maximal radiofrequency power

1 reference

https://api.crossref.org/works/10.1002%2FHEP.28266

21 January 2018

Evaluation of the Effect of Cumulative Operator Experience on Hepatocellular Carcinoma Recurrence after Primary Treatment with Radiofrequency Ablation

1 reference

https://api.crossref.org/works/10.1002%2FHEP.28266

21 January 2018

The secret of immortal time bias in epidemiologic studies.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.28266

21 January 2018

A new method of classifying prognostic comorbidity in longitudinal studies: development and validation

1 reference

https://api.crossref.org/works/10.1002%2FHEP.28266

21 January 2018

Recurrence of hepatitis B-related hepatocellular carcinoma is associated with high viral load at the time of resection.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.28266

21 January 2018

Risk of hepatocellular carcinoma in chronic hepatitis B: assessment and modification with current antiviral therapy.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.28266

21 January 2018

Impact of antiviral therapy on post-hepatectomy outcome for hepatitis B-related hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FHEP.28266

21 January 2018

Histological subclassification of cirrhosis can predict recurrence after curative resection of hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.28266

21 January 2018

Reversibility of hepatitis B virus cirrhosis after therapy: who and why?

1 reference

https://api.crossref.org/works/10.1002%2FHEP.28266

21 January 2018

Nonsteroidal anti-inflammatory drugs are associated with reduced risk of early hepatocellular carcinoma recurrence after curative liver resection: a nationwide cohort study

1 reference

https://api.crossref.org/works/10.1002%2FHEP.28266

21 January 2018

Risk factors for early and late recurrence in hepatitis B-related hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FHEP.28266

7 January 2021

based on heuristic

inferred from DOI database lookup

Hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1002%2FHEP.28266

7 January 2021

based on heuristic

inferred from DOI database lookup

The influence of hepatitis B DNA level and antiviral therapy on recurrence after initial curative treatment in patients with hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FHEP.28266

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/HEP.28266

1 reference

Europe PubMed Central

PubMed publication ID

29 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

29 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41277166&oldid=2095792456"